Global Agri-Food Advancement Partnership (GAAP) Invests in Biotech Startup Proxima Research & Development
Summary
Proxima has developed proprietary technology to better isolate, characterize, and engineer microbes for applications within agriculture, food, and pharma. Proxima offers unique microbial solutions to their clients, as well as developing their own technology solutions.SASKATOON, Saskatchewan Saskatchewans Global Agri-Food Advancement Partnership (GAAP) is excited to announce the recent close of an undisclosed investment round into Proxima Research and Development Canada.This advertisement has not loaded yet, but your article continues below.Subscribe now to read the latest news in your city and across Canada.Subscribe now to read the latest news in your city and across Canada.CEO of GAAP, Jay Robinson, says Having Proxima as part of the GAAP portfolio will expand our offering for the Canadian agriculture market. We are excited to support the growth of a company that has a wide range of expertise to share.Proxima has a vibrant and diverse research and development program which focuses on the isolation and genetic characterization of microbes with applications in food, biofuel, bioproducts, and pharmaceuticals. Zachery Belak, CEO and co-founder, and Iain Wallace, CSO and co-founder, say they benefit from Ag-West Bios on-going support, mentorship, and investments, and that participation in GAAPs incubator will help accelerate their business to the next stage.We are excited about this investment from GAAP because of the access to advanced equipment and facilities that it will provide. The company works as a catalyst for industry growth in the bioeconomy through investments, aiding strategic alliances, and providing business planning support, regulatory advice, and communications.